分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma

Zhao Qiangqiang, Sun Xiaoying, Wu Bin, Shang Yinghui, Huang Xueyuan, Dong Hang, Liu Haiting, Chen Wansong, Gui Rong, Li Jian

Journal:JOURNAL OF NANOBIOTECHNOLOGY

IF:10.44

DOI:10.1186/s12951-020-00738-8

PMID:33407527

Published:2021-01-06

research field:生物材料生物医学工程免疫学骨科组织工程

Abstract

Background Non-Hodgkin’s lymphoma (NHL) possesses great heterogeneity in cytogenetics, immunophenotype and clinical features, and chemotherapy currently serves as the main treatment modality. Although employing monoclonal antibody targeted drugs has significantly improved its overall efficacy, various patients continue to suffer from drug resistance or recurrence. Chinese medicine has long been used in the treatment of malignant tumors. Therefore, we constructed a low pH value sensitivity drug delivery system based on the cancer cell membrane modified mesoporous silica nanoparticles loaded with traditional Chinese medicine, which can reduce systemic toxicity and improve the therapeutic effect for the targeted drug delivery of tumor cells.Results Accordingly, this study put forward the construction of a nano-platform based on mesoporous silica nanoparticles (MSNs) loaded with the traditional Chinese medicine isoimperatorin (ISOIM), which was camouflaged by the cancer cell membrane (CCM) called CCM@MSNs-ISOIM. The proposed nano-platform has characteristics of immune escape, anti-phagocytosis, high drug loading rate, low pH value sensitivity, good biocompatibility and active targeting of the tumor site, blocking the lymphoma cell cycle and promoting mitochondrial-mediated apoptosis.Conclusion sFurthermore, this study provides a theoretical basis in finding novel clinical treatments for lymphoma.

本文使用的Yeasen产品

购物车
客服
转染试用